Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CONMED Co. stock logo
CNMD
CONMED
$55.38
-1.2%
$55.56
$46.00
$78.58
$1.73B1.19447,650 shs332,606 shs
Glaukos Co. stock logo
GKOS
Glaukos
$96.22
-1.0%
$93.43
$77.10
$163.71
$5.50B0.83696,970 shs829,075 shs
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
$142.69
+0.2%
$114.71
$55.92
$144.25
$4.56B1.34475,915 shs346,959 shs
Inari Medical, Inc. stock logo
NARI
Inari Medical
$79.97
$79.97
$39.76
$79.99
$4.68B1.021.33 million shsN/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CONMED Co. stock logo
CNMD
CONMED
-1.34%-8.05%+11.31%-9.20%-26.13%
Glaukos Co. stock logo
GKOS
Glaukos
-1.19%+0.81%+3.83%-23.65%-10.69%
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
+0.18%+1.20%+39.02%+19.32%+57.51%
Inari Medical, Inc. stock logo
NARI
Inari Medical
0.00%0.00%0.00%0.00%+67.76%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CONMED Co. stock logo
CNMD
CONMED
4.4989 of 5 stars
2.23.02.54.32.80.83.1
Glaukos Co. stock logo
GKOS
Glaukos
4.5988 of 5 stars
4.42.00.04.44.02.50.6
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
1.2356 of 5 stars
2.52.00.00.03.50.00.6
Inari Medical, Inc. stock logo
NARI
Inari Medical
0.574 of 5 stars
1.10.00.00.02.12.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CONMED Co. stock logo
CNMD
CONMED
2.40
Hold$62.2012.32% Upside
Glaukos Co. stock logo
GKOS
Glaukos
2.75
Moderate Buy$134.6739.95% Upside
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
2.91
Moderate Buy$133.73-6.28% Downside
Inari Medical, Inc. stock logo
NARI
Inari Medical
2.14
Hold$69.22-13.44% Downside

Current Analyst Ratings Breakdown

Latest CNMD, GKOS, NARI, and IRTC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/22/2025
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$130.00 ➝ $167.00
5/6/2025
Glaukos Co. stock logo
GKOS
Glaukos
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$110.00 ➝ $72.00
5/2/2025
Glaukos Co. stock logo
GKOS
Glaukos
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$140.00 ➝ $115.00
5/2/2025
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$152.00 ➝ $139.00
5/2/2025
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$133.00 ➝ $150.00
5/2/2025
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$104.00 ➝ $130.00
5/2/2025
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$138.00 ➝ $151.00
5/1/2025
CONMED Co. stock logo
CNMD
CONMED
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$70.00 ➝ $58.00
5/1/2025
CONMED Co. stock logo
CNMD
CONMED
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$70.00 ➝ $57.00
5/1/2025
CONMED Co. stock logo
CNMD
CONMED
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$91.00 ➝ $61.00
5/1/2025
Glaukos Co. stock logo
GKOS
Glaukos
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$140.00 ➝ $135.00
(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CONMED Co. stock logo
CNMD
CONMED
$1.32B1.30$6.07 per share9.13$31.15 per share1.78
Glaukos Co. stock logo
GKOS
Glaukos
$404.52M13.59N/AN/A$9.46 per share10.17
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
$618.59M7.36N/AN/A$6.85 per share20.83
Inari Medical, Inc. stock logo
NARI
Inari Medical
$493.63M9.48$0.09 per share906.95$8.07 per share9.91
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CONMED Co. stock logo
CNMD
CONMED
$132.42M$3.8013.0610.921.8310.13%14.31%5.64%7/30/2025 (Estimated)
Glaukos Co. stock logo
GKOS
Glaukos
-$134.66M-$2.37N/AN/AN/A-39.04%-16.53%-10.61%7/30/2025 (Estimated)
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
-$123.41M-$3.14N/AN/AN/A-19.14%-118.83%-11.34%8/7/2025 (Estimated)
Inari Medical, Inc. stock logo
NARI
Inari Medical
-$1.64M-$1.35N/A727.00N/A-13.68%-10.09%-6.60%N/A

Latest CNMD, GKOS, NARI, and IRTC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2025Q1 2025
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
-$0.89-$0.95-$0.06-$0.97$153.39 million$158.68 million
4/30/2025Q1 2025
CONMED Co. stock logo
CNMD
CONMED
$0.81$0.95+$0.14$0.19$313.38 million$321.26 million
4/30/2025Q1 2025
Glaukos Co. stock logo
GKOS
Glaukos
-$0.33-$0.22+$0.11-$0.32$102.78 million$106.66 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CONMED Co. stock logo
CNMD
CONMED
$0.801.44%N/A21.05%N/A
Glaukos Co. stock logo
GKOS
Glaukos
N/AN/AN/AN/AN/A
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
N/AN/AN/AN/AN/A
Inari Medical, Inc. stock logo
NARI
Inari Medical
N/AN/AN/AN/AN/A

Latest CNMD, GKOS, NARI, and IRTC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/21/2025
CONMED Co. stock logo
CNMD
CONMED
quarterly$0.201.34%6/13/20256/13/20257/3/2025
2/24/2025
CONMED Co. stock logo
CNMD
CONMED
quarterly$0.201.29%3/14/20253/14/20254/4/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CONMED Co. stock logo
CNMD
CONMED
0.94
2.30
1.06
Glaukos Co. stock logo
GKOS
Glaukos
0.19
5.54
4.71
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
9.00
6.27
6.12
Inari Medical, Inc. stock logo
NARI
Inari Medical
N/A
1.77
1.40

Institutional Ownership

CompanyInstitutional Ownership
CONMED Co. stock logo
CNMD
CONMED
N/A
Glaukos Co. stock logo
GKOS
Glaukos
99.04%
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
N/A
Inari Medical, Inc. stock logo
NARI
Inari Medical
90.98%

Insider Ownership

CompanyInsider Ownership
CONMED Co. stock logo
CNMD
CONMED
3.10%
Glaukos Co. stock logo
GKOS
Glaukos
5.80%
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
1.10%
Inari Medical, Inc. stock logo
NARI
Inari Medical
10.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
CONMED Co. stock logo
CNMD
CONMED
4,10030.94 million28.81 millionOptionable
Glaukos Co. stock logo
GKOS
Glaukos
78057.14 million51.61 millionOptionable
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
1,79031.93 million31.09 millionOptionable
Inari Medical, Inc. stock logo
NARI
Inari Medical
80058.54 million52.34 millionOptionable

Recent News About These Companies

The top nitinol cardiac medtech news of 2025 (so far)
8 spine, orthopedic acquisitions in Q1
Stryker grows cardiovascular division with Inari Medical acquisition
Stryker Completes Acquisition of Inari
Stryker concludes Inari Medical acquisition for $4.9bn
Stryker completes Inari Medical acquisition
Stryker completes acquisition of Inari Medical

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
CONMED stock logo

CONMED NYSE:CNMD

$55.38 -0.68 (-1.22%)
Closing price 05/23/2025 03:59 PM Eastern
Extended Trading
$55.39 +0.02 (+0.03%)
As of 05/23/2025 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Glaukos stock logo

Glaukos NYSE:GKOS

$96.22 -0.97 (-0.99%)
Closing price 05/23/2025 03:59 PM Eastern
Extended Trading
$99.06 +2.84 (+2.95%)
As of 05/23/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

iRhythm Technologies stock logo

iRhythm Technologies NASDAQ:IRTC

$142.69 +0.25 (+0.18%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$142.60 -0.09 (-0.06%)
As of 05/23/2025 06:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Inari Medical stock logo

Inari Medical NASDAQ:NARI

$79.97 0.00 (0.00%)
As of 02/19/2025

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.